Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comprehensive HIV Prevention Package for MSM in Southern Africa
NCT02043015Completed
- Sponsor
- Emory University
- Start
- Feb 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Open-label trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Emory University. Primary endpoints: Retention in the Cohort at 12 months and Use of Pre-exposure Prophylaxis at 4 months. Started Feb 2015; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02043015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02043015.